Research progress of psychological intervention assisted gold nanoparticles drug delivery in the treatment of triple-negative breast cancer patients

  • Yu Zhao Medical Laboratory, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, Shanghai 200438, China; Department of Genetics and Cell Biology, School of Basic Medicine, Qingdao University, Qingdao, Shandong 266071, China
  • Zien Cheng Medical Laboratory, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, Shanghai 200438, China
  • Cui Zhang Medical Laboratory, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, Shanghai 200438, China
  • Aijuan Jiang Medical Laboratory, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, Shanghai 200438, China
  • Jinfeng Shao Medical Laboratory, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, Shanghai 200438, China
  • Xiaoyan Ma Medical Laboratory, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, Shanghai 200438, China
  • Xiaolei Dong * Department of Genetics and Cell Biology, School of Basic Medicine, Qingdao University, Qingdao, Shandong 266071, China
Article ID: 4477
6 Views
DOI: https://doi.org/10.18282/po4477
Keywords: gold nanoparticles; triple-negative breast cancer; drug delivery; psychological intervention; AuNPs antibody complex

Abstract

Objective: Breast cancer represents the most prevalent malignant tumor among women worldwide. Among the subtypes of breast cancer, triple-negative breast cancer (TNBC) exhibits the highest rates of recurrence and mortality. Early diagnosis and effective treatment play a crucial role in delaying the progression of TNBC, prolonging patient survival, and enhancing the quality of life. Therapeutic strategies that leverage gold nanoparticles for targeted drug delivery show significant potential in improving outcomes for patients with TNBC, and adjuvant therapy with early psychological intervention for patients has also attracted much attention. This paper reviews the current advancements in the application of psychological intervention combined with gold nanoparticles in targeted drug delivery and treatment strategies for TNBC, providing a theoretical framework for their clinical application in managing this aggressive breast cancer subtype. Methods: Literature in this article was obtained primarily by searching the PubMed database. We used keywords to search articles: breast cancer, triple-negative breast cancer, nanoparticles, gold nanoparticles, drug delivery, psychological intervention, drug therapy. Results: We found that targeted drug delivery with gold nanoparticles was significantly effective in the treatment of TNBC patients, but psychological intervention assisted targeted drug delivery with gold nanoparticles was significant for improving the survival time and quality of life of patients. Conclusion: Therapeutic strategies for targeted drug delivery with gold nanoparticles are increasing and technology is becoming more and more mature. Targeted drug delivery with gold nanoparticles combined with psychological intervention can effectively delay the process of disease development while improving the survival beliefs of patients with TNBC.

Published
2025-08-25
How to Cite
Zhao, Y., Cheng, Z., Zhang, C., Jiang, A., Shao, J., Ma, X., & Dong, X. (2025). Research progress of psychological intervention assisted gold nanoparticles drug delivery in the treatment of triple-negative breast cancer patients. Psycho-Oncologie, 19(3), 4477. https://doi.org/10.18282/po4477
Issue
Vol. 19 No. 3 (2025)
Section
Review

Copyright (c) 2025 Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA: A Cancer Journal for Clinicians. 2024; 74(1): 12-49. doi: 10.3322/caac.21820

2. Zagami P, Carey LA. Triple negative breast cancer: Pitfalls and progress. NPJ Breast Cancer. 2022; 8(1). doi: 10.1038/s41523-022-00468-0

3. Wei R, Fu G, Li Z, et al. Au-Fe3O4 Janus nanoparticles for imaging-guided near infrared-enhanced ferroptosis therapy in triple negative breast cancer. Journal of Colloid and Interface Science. 2024; 663: 644-655. doi: 10.1016/j.jcis.2024.02.201

4. Shi HX, Tao HT, He JJ, et al. Targeting DKK1 enhances the antitumor activity of paclitaxel and alleviates chemotherapy-induced peripheral neuropathy in breast cancer. Molecular Cancer. 2024; 23(1). doi: 10.1186/s12943-024-02067-y

5. Jiang Z, Ouyang Q, Sun T, et al. Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial. Nature Medicine. 2024; 30(1): 249-256. doi: 10.1038/s41591-023-02677-x

6. Dent R, André F, Gonçalves A, et al. IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer. Annals of Oncology. 2024; 35(7): 630-642. doi: 10.1016/j.annonc.2024.04.001

7. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2024; 74(3): 229-263. doi: 10.3322/caac.21834

8. Kang S, Bhang SH, Hwang S, et al. Mesenchymal Stem Cells Aggregate and Deliver Gold Nanoparticles to Tumors for Photothermal Therapy. ACS Nano. 2015; 9(10): 9678-9690. doi: 10.1021/acsnano.5b02207

9. Zhang D, Wu T, Qin X, et al. Intracellularly Generated Immunological Gold Nanoparticles for Combinatorial Photothermal Therapy and Immunotherapy against Tumor. Nano Letters. 2019; 19(9): 6635-6646. doi: 10.1021/acs.nanolett.9b02903

10. Patel RB, Ye M, Carlson PM, et al. Development of an In Situ Cancer Vaccine via Combinational Radiation and Bacterial‐Membrane‐Coated Nanoparticles. Advanced Materials. 2019; 31(43). doi: 10.1002/adma.201902626

11. Goldberg MS. Improving cancer immunotherapy through nanotechnology. Nature Reviews Cancer. 2019; 19(10): 587-602. doi: 10.1038/s41568-019-0186-9

12. McGregor BA, Antoni MH. Psychological intervention and health outcomes among women treated for breast cancer: A review of stress pathways and biological mediators. Brain, Behavior, and Immunity. 2009; 23(2): 159-166. doi: 10.1016/j.bbi.2008.08.002

13. Bright EE, Finkelstein LB, Nealis MS, et al. A Systematic Review and Meta-Analysis of Interventions to Promote Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors. Journal of Clinical Oncology. 2023; 41(28): 4548-4561. doi: 10.1200/jco.23.00697

14. Zhang Y, Chen X, Zhang H, et al. Facile Exfoliation for High-Quality Molybdenum Disulfide Nanoflakes and Relevant Field-Effect Transistors Developed with Thermal Treatment. Frontiers in Chemistry. 2021; 9. doi: 10.3389/fchem.2021.650901

15. Elbialy NS, Fathy MM, AL-Wafi R, et al. Multifunctional magnetic-gold nanoparticles for efficient combined targeted drug delivery and interstitial photothermal therapy. International Journal of Pharmaceutics. 2019; 554: 256-263. doi: 10.1016/j.ijpharm.2018.11.021

16. del Pilar Chantada-Vázquez M, López AC, Vence MG, et al. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers. Journal of Proteomics. 2020; 212: 103581. doi: 10.1016/j.jprot.2019.103581

17. Cortes J, Cescon DW, Rugo HS, et al. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (keynote-355): A randomised, placebo-controlled, double-blind, phase 3 clinical trial [J]. Lancet, 2020, 396(10265): 1817-28. doi: 10.1016/S0140-6736(20)32531-9.

18. Harris MA, Savas P, Virassamy B, et al. Towards targeting the breast cancer immune microenvironment. Nature Reviews Cancer. 2024; 24(8): 554-577. doi: 10.1038/s41568-024-00714-6

19. Mao Q, Fang J, Wang A, et al. Aggregation of Gold Nanoparticles Triggered by Hydrogen Peroxide‐Initiated Chemiluminescence for Activated Tumor Theranostics. Angewandte Chemie International Edition. 2021; 60(44): 23805-23811. doi: 10.1002/anie.202109863

20. Dozie-Nwachukwu SO, Obayemi JD, Danyuo Y, et al. A comparative study of the adhesion of biosynthesized gold and conjugated gold/prodigiosin nanoparticles to triple negative breast cancer cells. Journal of Materials Science: Materials in Medicine. 2017; 28(9). doi: 10.1007/s10856-017-5943-2

21. Du Y, Yang C, Li F, et al. Core–Shell–Satellite Nanomaces as Remotely Controlled Self‐Fueling Fenton Reagents for Imaging‐Guided Triple‐Negative Breast Cancer‐Specific Therapy. Small. 2020; 16(31). doi: 10.1002/smll.202002537

22. Jiang H, Zhou Y, Zheng D, et al. Using anti‐PD‐L1 antibody conjugated gold nanoshelled poly (Lactic‐co‐glycolic acid) nanocapsules loaded with doxorubicin: A theranostic agent for ultrasound imaging and photothermal/chemo combination therapy of triple negative breast cancer. Journal of Biomedical Materials Research Part A. 2023; 112(3): 402-420. doi: 10.1002/jbm.a.37638

23. Ayala-Orozco C, Urban C, Bishnoi S, et al. Sub-100nm gold nanomatryoshkas improve photo-thermal therapy efficacy in large and highly aggressive triple negative breast tumors. Journal of Controlled Release. 2014; 191: 90-97. doi: 10.1016/j.jconrel.2014.07.038

24. Nie Y, Liang Z, Wang P, et al. MXene-Derived Quantum Dot@Gold Nanobones Heterostructure-Based Electrochemiluminescence Sensor for Triple-Negative Breast Cancer Diagnosis. Analytical Chemistry. 2021; 93(51): 17086-17093. doi: 10.1021/acs.analchem.1c04184

25. Wang D, Nie Y, Wang P, et al. In situ synthesis of Cu nanoclusters/CeO2 nanorod as aggregated induced ECL probe for triple-negative breast cancer detection. Talanta. 2023; 258: 124400. doi: 10.1016/j.talanta.2023.124400

26. Cai Y, Zhu B, Shan X, et al. Inhibiting Endothelial Cell‐Mediated T Lymphocyte Apoptosis with Integrin‐Targeting Peptide‐Drug Conjugate Filaments for Chemoimmunotherapy of Triple‐Negative Breast Cancer. Advanced Materials. 2023; 36(3). doi: 10.1002/adma.202306676

27. Setyawati MI, Wang Q, Ni N, et al. Engineering tumoral vascular leakiness with gold nanoparticles. Nature Communications. 2023; 14(1). doi: 10.1038/s41467-023-40015-4

28. Fan L, Wang W, Wang Z, et al. Gold nanoparticles enhance antibody effect through direct cancer cell cytotoxicity by differential regulation of phagocytosis. Nature Communications. 2021; 12(1). doi: 10.1038/s41467-021-26694-x

29. Song C, Ji S, Sun H, et al. An Unconventional Immunosensor for Biomolecule Detection via Nonspecific Gold Nanoparticle–Antibody Interactions. Analytical Chemistry. 2024; 96(19): 7367-7372. doi: 10.1021/acs.analchem.4c00598

30. Yan GH, Wang K, Shao Z, et al. Artificial antibody created by conformational reconstruction of the complementary-determining region on gold nanoparticles. Proceedings of the National Academy of Sciences. 2017; 115(1). doi: 10.1073/pnas.1713526115

31. Stahl P, Kollenda S, Sager J, et al. Tuning Nanobodies’ Bioactivity: Coupling to Ultrasmall Gold Nanoparticles Allows the Intracellular Interference with Survivin. Small. 2023; 19(33). doi: 10.1002/smll.202300871

32. Spring LM, Tolaney SM, Fell G, et al. Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial. Annals of Oncology. 2024; 35(3): 293-301. doi: 10.1016/j.annonc.2023.11.018

33. Song T, Cooper L, Galván Achi J, et al. Polyvalent Nanobody Structure Designed for Boosting SARS-CoV-2 Inhibition. Journal of the American Chemical Society. 2024; 146(9): 5894-5900. doi: 10.1021/jacs.3c11760

34. Zhang Q, Liang J, Bongers A, et al. Site‐Specific Antibody Assembly on Nanoparticles via a Versatile Coating Method for Improved Cell Targeting. Advanced Science. 2023; 10(9). doi: 10.1002/advs.202206546

35. Xia Q, Mu Z, Qing M, et al. A sandwich-type electrochemical immunosensor for sensitive detection of HER2 based on dual signal amplification of La-MOF-PbO2 and PEI-MoS2NFs composites. Bioelectrochemistry. 2023; 152: 108431. doi: 10.1016/j.bioelechem.2023.108431

36. Cai Z, Liu R, Chan C, et al. 90Y-Labeled Gold Nanoparticle Depot (NPD) Combined with Anti-PD-L1 Antibodies Strongly Inhibits the Growth of 4T1 Tumors in Immunocompetent Mice and Induces an Abscopal Effect on a Distant Non-Irradiated Tumor. Molecular Pharmaceutics. 2022; 19(11): 4199-4211. doi: 10.1021/acs.molpharmaceut.2c00572

37. Tang J, Howard CB, Mahler SM, et al. Enhanced delivery of siRNA to triple negative breast cancer cells in vitro and in vivo through functionalizing lipid-coated calcium phosphate nanoparticles with dual target ligands. Nanoscale. 2018; 10(9): 4258-4266. doi: 10.1039/c7nr08644j

38. Tang J, Li B, Howard CB, et al. Multifunctional lipid-coated calcium phosphate nanoplatforms for complete inhibition of large triple negative breast cancer via targeted combined therapy. Biomaterials. 2019; 216: 119232. doi: 10.1016/j.biomaterials.2019.119232

39. Xiao L, Chen B, Wang W, et al. Multifunctional Au@AgBiS2 Nanoparticles as High‐Efficiency Radiosensitizers to Induce Pyroptosis for Cancer Radioimmunotherapy. Advanced Science. 2023; 10(30). doi: 10.1002/advs.202302141

40. Farooq MU, Sahin YM, Naz MY, et al. Surface engineered AuNPs for paclitaxel-loaded bleomycin delivery as a supplementation therapy. Applied Nanoscience. 2022; 12(12): 3883-3899. doi: 10.1007/s13204-022-02645-w

41. Kashkooli FM, Jakhmola A, A Ferrier G, et al. Development of an ultrasound-mediated nano-sized drug-delivery system for cancer treatment: from theory to experiment. Nanomedicine. Published online May 9, 2024: 1-23. doi: 10.2217/nnm-2023-0259

42. Farooq MU, Dovzhenko AP, Zairov RR, et al. Insights into the Engineered Gold Nanoparticle-Based Remedy for Supplementation Therapy of Ovarian Carcinoma. ACS Omega. 2024. doi: 10.1021/acsomega.4c04134

43. Moradi Kashkooli F, Jakhmola A, Hornsby TK, et al. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions. Journal of Controlled Release. 2023; 355: 552-578. doi: 10.1016/j.jconrel.2023.02.009

44. Hornsby TK, Kashkooli FM, Jakhmola A, et al. Kinetic modelling of ultrasound-triggered chemotherapeutic drug release from the surface of gold nanoparticles. Scientific Reports. 2023; 13(1). doi: 10.1038/s41598-023-48082-9

45. Jakhmola A, Hornsby TK, Kashkooli FM, et al. Green synthesis of anti-cancer drug-loaded gold nanoparticles for low-intensity pulsed ultrasound targeted drug release. Drug Delivery and Translational Research. 2024; 14(9): 2417-2432. doi: 10.1007/s13346-024-01516-x

46. Dong S, Huang Y, Yan H, et al. Ternary heterostructure-driven photoinduced electron-hole separation enhanced oxidative stress for triple-negative breast cancer therapy. Journal of Nanobiotechnology. 2024; 22(1). doi: 10.1186/s12951-024-02530-4

47. Vayalakkara RK, Lo CL, Chen HH, et al. Photothermal/NO combination therapy from plasmonic hybrid nanotherapeutics against breast cancer. Journal of Controlled Release. 2022; 345: 417-432. doi: 10.1016/j.jconrel.2022.03.030

48. Zhong W, Zhang Y, Zhao H, et al. High electrochemical active Au-NP/2D zinc-metal organic frameworks heterostructure-based ECL sensor for the miRNA-522 detection in triple negative breast cancer. Talanta. 2023; 265: 124875. doi: 10.1016/j.talanta.2023.124875

49. Zhao J, Babiuch K, Lu H, et al. Fructose-coated nanoparticles: a promising drug nanocarrier for triple-negative breast cancer therapy. Chem Commun. 2014; 50(100): 15928-15931. doi: 10.1039/c4cc06651k

50. Li K, Lin C, Li M, et al. Multienzyme-like Reactivity Cooperatively Impairs Glutathione Peroxidase 4 and Ferroptosis Suppressor Protein 1 Pathways in Triple-Negative Breast Cancer for Sensitized Ferroptosis Therapy. ACS Nano. 2022; 16(2): 2381-2398. doi: 10.1021/acsnano.1c08664

51. Saravanakumar K, Sathiyaseelan A, Manivasagan P, et al. Multifunctional chitosan-bimetallic nanocarrier deliver 5-fluorouracil for enhanced treatment of pancreatic and triple-negative breast cancer. International Journal of Biological Macromolecules. 2024; 259: 129165. doi: 10.1016/j.ijbiomac.2023.129165

52. Sorolla A, Wang E, Clemons TD, et al. Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides. Nanomedicine: Nanotechnology, Biology and Medicine. 2019; 20: 102003. doi: 10.1016/j.nano.2019.04.006

53. Landgraf M, Lahr CA, Kaur I, et al. Targeted camptothecin delivery via silicon nanoparticles reduces breast cancer metastasis. Biomaterials. 2020; 240: 119791. doi: 10.1016/j.biomaterials.2020.119791

54. Goel S, Ferrari M, Shen H. Surface Engineering and Multimodal Imaging of Multistage Delivery Vectors in Metastatic Breast Cancer. Bio-Protocol. 2021; 11(10). doi: 10.21769/bioprotoc.4030

55. Liu X, Liu J, Xu S, et al. Gold Nanoparticles Functionalized with Au–Se-Bonded Peptides Used as Gatekeepers for the Off-Target Release of Resveratrol in the Treatment of Triple-Negative Breast Cancer. ACS Applied Materials & Interfaces. 2023; 15(2): 2529-2537. doi: 10.1021/acsami.2c10221

56. Hanalis-Miller T, Ricon-Becker I, Sakis N, et al. Peri-operative individually tailored psychological intervention in breast cancer patients improves psychological indices and molecular biomarkers of metastasis in excised tumors. Brain, Behavior, and Immunity. 2024; 117: 529-540. doi: 10.1016/j.bbi.2024.02.009

57. Post KE, Aribindi S, Traeger L, et al. Not out of the woods: perspectives from patients with triple-negative breast cancer. Supportive Care in Cancer. 2024; 33(1). doi: 10.1007/s00520-024-09084-z

58. Miranda TPS, Caldeira S, de Oliveira HF, et al. Intercessory Prayer on Spiritual Distress, Spiritual Coping, Anxiety, Depression and Salivary Amylase in Breast Cancer Patients During Radiotherapy: Randomized Clinical Trial. Journal of Religion and Health. 2019; 59(1): 365-380. doi: 10.1007/s10943-019-00827-5

59. Halkett G, O’Connor M, et al. RT Prepare: a radiation therapist-delivered intervention reduces psychological distress in women with breast cancer referred for radiotherapy. British Journal of Cancer. 2018; 118(12): 1549-1558. doi: 10.1038/s41416-018-0112-z

60. Dent R, Cortés J, Pusztai L, et al. Neoadjuvant pembrolizumab plus chemotherapy/adjuvant pembrolizumab for early-stage triple-negative breast cancer: quality-of-life results from the randomized KEYNOTE-522 study. JNCI: Journal of the National Cancer Institute. 2024; 116(10): 1654-1663. doi: 10.1093/jnci/djae129